Zai Lab Ltd — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2021-07-13

Reporting Person: Reinhart Harald (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-13	Ordinary Shares	M	8000	$18.00	Acquired	8000	Direct
2021-07-13	Ordinary Shares	S	8000	$169.92	Disposed	0	Direct
2021-07-14	Ordinary Shares	M	4000	$18.00	Acquired	4000	Direct
2021-07-14	Ordinary Shares	S	4000	$169.11	Disposed	0	Direct
2021-07-14	Ordinary Shares	M	4000	$17.99	Acquired	4000	Direct
2021-07-14	Ordinary Shares	S	4000	$169.11	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-13	Stock Options (Right to Buy)	$18.00	M	8000	Disposed	2027-09-20	Ordinary Shares (8000)	Direct
2021-07-14	Stock Options (Right to Buy)	$18.00	M	4000	Disposed	2027-09-20	Ordinary Shares (4000)	Direct
2021-07-14	Stock Options (Right to Buy)	$17.99	M	4000	Disposed	2028-11-16	Ordinary Shares (4000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant.

F3: The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant.